These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2650879

  • 1. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks.
    Andersson PG, Hinge HH, Johansen O, Andersen CU, Lademann A, Gøtzsche PC.
    Cephalalgia; 1989 Mar; 9(1):29-32. PubMed ID: 2650879
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Naproxen and naproxen sodium in acute migraine attacks.
    Nestvold K.
    Cephalalgia; 1986 Mar; 6 Suppl 4():81-4. PubMed ID: 3539361
    [No Abstract] [Full Text] [Related]

  • 6. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks.
    Treves TA, Streiffler M, Korczyn AD.
    Headache; 1992 Jun; 32(6):280-2. PubMed ID: 1399547
    [Abstract] [Full Text] [Related]

  • 11. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
    Landy SH, Cady RK, Nelsen A, White J, Runken MC.
    Headache; 2014 Apr; 54(4):640-54. PubMed ID: 24102322
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis.
    Bellavance AJ, Meloche JP.
    Headache; 1990 Nov; 30(11):710-5. PubMed ID: 2074163
    [Abstract] [Full Text] [Related]

  • 18. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache.
    Sargent J, Solbach P, Damasio H, Baumel B, Corbett J, Eisner L, Jessen B, Kudrow L, Mathew N, Medina J.
    Headache; 1985 Sep; 25(6):320-4. PubMed ID: 3902723
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
    Cady R, Nett R, Dexter K, Freitag F, Beach ME, Manley HR.
    Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.